United States · Venture startup

Who invested in Provista Diagnostics

6 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$29Mraised across 6 rounds since 2012, from 6 sources

$6.0MSeries A$6.0MSeries B$6.0MVenture
Latest round
Venture, $6.0MAug 2015
Step-upi
1.6×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012201320142015
$5.0MSeries A$2.5MSeries A$6.0MSeries A$6.0MSeries B$3.9MVenture$6.0MVenture
First round
Series A, $5.0M
Mar 2012
Biggest round
$6.0M
Venture · Aug 2015
Usual gap between rounds
7 months
the median of 5

The rounds

  1. Aug 2015
    Venture$6.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $6.0M sold, first sale Jul 2015

  2. Mar 2015
    Venture$3.9M

    No investor was named in the report.

    From a historical funding recordSEC filing: $3.9M sold, first sale Feb 2015

  3. Apr 2014
    Series B$6.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $6.0M sold, first sale Apr 2014

  4. Apr 2013
    Series A$6.0M

    No investor was named in the report.

    Reported by pevc.dowjones.comSEC filing: $6.0M sold, first sale Apr 2013

  5. Sept 2012
    Series A$2.5M

    No investor was named in the report.

    Reported by pevc.dowjones.comSEC filing: $7.5M sold, first sale Feb 2012

  6. Mar 2012
    Series A$5.0M

    No investor was named in the report.

    Reported by provistadx.comSEC filing: $4.5M sold, first sale Feb 2012

Funding filed with regulators

Provista Diagnostics filed 9 raises, $42M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. May 2018$2.2M6 investorsequity, debtof $5.0M offeredSEC Form D
  2. Jul 2017$2.3M28 investorsequity, debtof $4.0M offeredSEC Form D
  3. Oct 2016$2.6M5 investorsequity, debtof $6.0M offeredSEC Form D
  4. Mar 2016$5.1M25 investorsequitySEC Form D
  5. Jul 2015$6.0M27 investorsequitySEC Form D
  6. Feb 2015$3.9M24 investorsequitySEC Form D
  7. Apr 2014$6.0M34 investorsequity, options, securities on exerciseSEC Form D
  8. Apr 2013$6.0M35 investorsequity, options, securities on exerciseof $6.0M offeredSEC Form D
  9. Feb 2012$7.5M32 investorsequity, options, securities on exerciseSEC Form D

Founders and team

From the SEC filings it signed: 4 on the team.

  • Gary AltmanExecutive Officer, Directori
  • John G. FermanisExecutive Officeri
  • Rao G. MulpuriExecutive Officeri
  • Uriel E. KusiatinExecutive Officeri

On the board, as filediCynthia E. CollinsJack J. LevineJeffrey R. GilmanJohn G. ZicarelliJohn J. MacaskillRobert J. HaririThomas G. MendellYoji G. Nimura

Quick answers about Provista Diagnostics

How much has Provista Diagnostics raised?

Provista Diagnostics has raised $29M across 6 rounds since 2012.

When did Provista Diagnostics last raise?

Provista Diagnostics's most recent round was a Venture of $6.0M in Aug 2015.

What was Provista Diagnostics's biggest round?

Its most recent round, $6.0M in Aug 2015, is also its largest on record.

What stage is Provista Diagnostics at?

Provista Diagnostics's latest named round is a Venture, in Aug 2015.

Where is Provista Diagnostics based?

Provista Diagnostics is based in the United States.

Companies like Provista Diagnostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.